Dr Reddy's April-June quarter earnings have surpassed street estimates with net profit rising 14 percent to Rs 626 crore from Rs 550.4 crore in corresponding quarter last fiscal. Total income, - See more at: http://ways2capital-review.blogspot.in/2015/07/dr-reddys-q1-beats-street-net-rises-14.html#sthash.88GdPtaK.dpuf

Dr Reddy's April-June quarter earnings have surpassed street estimates with net profit rising 14 percent to Rs 626 crore from Rs 550.4 crore in corresponding quarter last fiscal. Total income, - See more at: http://ways2capital-review.blogspot.in/2015/07/dr-reddys-q1-beats-street-net-rises-14.html#sthash.88GdPtaK.dpuf

The Sensex closed down 11.83 points at 31209.79, while the Nifty down 1.70 points at 9613.30. The market breadth was very narrow as 1333 shares advanced against a decline of 1327 shares, while 135 shares were unchanged. Reliance, HDFC and BPCL were the top gainers, while Hero MotoCorp, Axis Bank, Indiabulls Housing and Dr Reddy’s Laboratories. For More Information Please Visit : www.paceresearchindia.com and Call : 8817774774

The Sensex closed down 11.83 points at 31209.79, while the Nifty down 1.70 points at 9613.30. The market breadth was very narrow as 1333 shares advanced against a decline of 1327 shares, while 135 shares were unchanged. Reliance, HDFC and BPCL were the top gainers, while Hero MotoCorp, Axis Bank, Indiabulls Housing and Dr Reddy’s Laboratories. For More Information Please Visit : www.paceresearchindia.com and Call : 8817774774

Share and Stock Market Tips: Indian ADRs: Infosys, Dr Reddy's Laboratories, Wip...

Share and Stock Market Tips: Indian ADRs: Infosys, Dr Reddy's Laboratories, Wip...

The S&P BSE Sensex started on a cautious note on Wednesday following muted trend seen in other Asian markets. The fall in the index was led by losses in Dr Reddy's Laboratories, HDFC, Bharti Airtel, and ICICI Bank.  Get Expert Advice for Stock and Commodity Market Trading  www.marketmagnify.com/stock-cash-tips.php

The S&P BSE Sensex started on a cautious note on Wednesday following muted trend seen in other Asian markets. The fall in the index was led by losses in Dr Reddy's Laboratories, HDFC, Bharti Airtel, and ICICI Bank. Get Expert Advice for Stock and Commodity Market Trading www.marketmagnify.com/stock-cash-tips.php

Shares of Dr Reddy's Laboratories rose 1.8 percent to touch a life high of Rs 3,827.10 on the Bombay Stock Exchange Tuesday. - See more at: http://ways2capital-review.blogspot.in/2015/07/dr-reddys-hits-new-high-on-alzheimers.html#sthash.UTGluNQo.dpuf

Shares of Dr Reddy's Laboratories rose 1.8 percent to touch a life high of Rs 3,827.10 on the Bombay Stock Exchange Tuesday. - See more at: http://ways2capital-review.blogspot.in/2015/07/dr-reddys-hits-new-high-on-alzheimers.html#sthash.UTGluNQo.dpuf

Dr. Reddy's Laboratories announced today that it has entered into a licensing agreement with Eisai Co., Ltd, Japan by which Dr. Reddy's - See more at: http://ways2capital-equitytips.blogspot.in/2016/03/dr-reddys-acquires-e7777s-rights-from.html#sthash.xu9xy51H.dpuf

Dr. Reddy's Laboratories announced today that it has entered into a licensing agreement with Eisai Co., Ltd, Japan by which Dr. Reddy's - See more at: http://ways2capital-equitytips.blogspot.in/2016/03/dr-reddys-acquires-e7777s-rights-from.html#sthash.xu9xy51H.dpuf

The colour purple that has left drug makers like Dr Reddy's Laboratories pale | ET HealthWorld

The colour purple that has left drug makers like Dr Reddy's Laboratories pale | ET HealthWorld

Indian ADRs ended in red on Monday. In the IT space, Infosys shd 0.49 percent at USD 16.74 and Wipro declined 0.13 percent at USD 12.13. In the banking space, ICICI Bank was down 0.17 percent at USD 9.56 and HDFC Bank fell 0.44 percent at USD 61.07. In the other sectors, Tata Motors slipped 1.01 percent at USD 28.72 and Dr Reddy's Laboratories fell 0.48 percent at USD 60.63. - See more at: http://ways2capital.blogspot.in/2015/07/indian-adrs-tata-motors-hdfc-bank.html#sthash.Chy6nSiQ.dpuf

Indian ADRs ended in red on Monday. In the IT space, Infosys shd 0.49 percent at USD 16.74 and Wipro declined 0.13 percent at USD 12.13. In the banking space, ICICI Bank was down 0.17 percent at USD 9.56 and HDFC Bank fell 0.44 percent at USD 61.07. In the other sectors, Tata Motors slipped 1.01 percent at USD 28.72 and Dr Reddy's Laboratories fell 0.48 percent at USD 60.63. - See more at: http://ways2capital.blogspot.in/2015/07/indian-adrs-tata-motors-hdfc-bank.html#sthash.Chy6nSiQ.dpuf

#ClosingBell : Benchmark indices ended the session on a flat note with a negative bias, but the Nifty ended above 9600-mark. The #Sensex closed down 11.83 points at 31209.79, while the #Nifty down 1.70 points at 9613.30. The market breadth was very narrow as 1333 shares advanced against a decline of 1327 shares, while 135 shares were unchanged. Reliance, HDFC and BPCL were the top gainers, while Hero MotoCorp, Axis Bank, Indiabulls Housing and Dr Reddy’s Laboratories.

#ClosingBell : Benchmark indices ended the session on a flat note with a negative bias, but the Nifty ended above 9600-mark. The #Sensex closed down 11.83 points at 31209.79, while the #Nifty down 1.70 points at 9613.30. The market breadth was very narrow as 1333 shares advanced against a decline of 1327 shares, while 135 shares were unchanged. Reliance, HDFC and BPCL were the top gainers, while Hero MotoCorp, Axis Bank, Indiabulls Housing and Dr Reddy’s Laboratories.

Hyderabad-based company, Dr Reddy's Laboratories, declared here nowadays that it's launched over-the-counter (OTC) Fexofenadine coordination compound and alkaloid coordination compound in North American nation market increasing their power to sixty and one hundred twenty mg severally.

Hyderabad-based company, Dr Reddy's Laboratories, declared here nowadays that it's launched over-the-counter (OTC) Fexofenadine coordination compound and alkaloid coordination compound in North American nation market increasing their power to sixty and one hundred twenty mg severally.

Dr. Reddy’s Laboratories Ltd has signed MoU with Life Sciences Sector Skill Development Council and Vishnu Institute of Pharmaceutical Education and Research to Strengthen the Skilled Labour Pool in the Life Science Industry. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/dr-reddys-laboratories-signs-mou-with.html#sthash.fxL8msiy.dpuf

Dr. Reddy’s Laboratories Ltd has signed MoU with Life Sciences Sector Skill Development Council and Vishnu Institute of Pharmaceutical Education and Research to Strengthen the Skilled Labour Pool in the Life Science Industry. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/dr-reddys-laboratories-signs-mou-with.html#sthash.fxL8msiy.dpuf

Drugmaker Dr Reddy's Laboratories said it has signed a commercialisation deal with Australia's Hatchtech for the latter's prescription head lice product Xeglyze Lotion. - See more at: http://ways2capital-review.blogspot.in/2015/09/dr-reddys-signs-commercialisation-deal.html#sthash.HGFJaUwH.dpuf

Drugmaker Dr Reddy's Laboratories said it has signed a commercialisation deal with Australia's Hatchtech for the latter's prescription head lice product Xeglyze Lotion. - See more at: http://ways2capital-review.blogspot.in/2015/09/dr-reddys-signs-commercialisation-deal.html#sthash.HGFJaUwH.dpuf

Dr Reddy's Laboratories stock was down by 2% at Rs.3076. Report says that US Consumer Product Safety Commission, has pleaded to the US Department of Justice, seeking civil penalty against the company.

Dr Reddy's Laboratories stock was down by 2% at Rs.3076. Report says that US Consumer Product Safety Commission, has pleaded to the US Department of Justice, seeking civil penalty against the company.

Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA

Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA

Dr. Reddy's Laboratories continues European hospital market expansion

Dr. Reddy's Laboratories continues European hospital market expansion

Benchmark indices ended the session on a flat note with a negative bias, but the Nifty ended above 9600-mark. The #Sensex closed down 11.83 points at 31209.79, while the #Nifty down 1.70 points at 9613.30. The market breadth was very narrow as 1333 shares advanced against a decline of 1327 shares, while 135 shares were unchanged. Reliance, HDFC and BPCL were the top gainers, while Hero MotoCorp, Axis Bank, Indiabulls Housing and Dr Reddy’s Laboratories. #MoneyMakerResearch

Benchmark indices ended the session on a flat note with a negative bias, but the Nifty ended above 9600-mark. The #Sensex closed down 11.83 points at 31209.79, while the #Nifty down 1.70 points at 9613.30. The market breadth was very narrow as 1333 shares advanced against a decline of 1327 shares, while 135 shares were unchanged. Reliance, HDFC and BPCL were the top gainers, while Hero MotoCorp, Axis Bank, Indiabulls Housing and Dr Reddy’s Laboratories. #MoneyMakerResearch

Pinterest
Search